loader2
NRI

Dec 11, 2024

Category

Others

AUM (Cr.)

852.28

Exit Load (%)

0.00

Min Inv Lumpsum

1,000

Expense Ratio

0.21

Sharpe Ratio

19.75

Beta Ratio

0.00

Fund Manager

Himanshu Mange

Inception Date

Jul 06, 2021

Risk Level

Very High

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

Invest Now
Nifty Pharma TRI

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Nifty Pharma ETF -0.2 13.57 39.54 19 0 14.19
Benchmark - Nifty Pharma TRI -1.11 13.21 38.84 19.27 23.84 0
Category Average - BEST ETFS/INDEX 2.57 7.82 24.52 15.03 17.06 20.08
Category Rank 3/1 3/1 1/1 1/1 2/1 1/1
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Mirae Asset NYSE FANG+ ETF 112.0006 2.93 62.50 25.12 0.00 2,387.19 0.00 5,000.00 invest
Motilal Oswal NASDAQ-100 ETF 180.3357 1.84 36.50 14.78 25.53 8,222.53 0.58 10,000.00 invest
Mirae Asset S&P 500 Top 50 ETF 48.7702 1.28 42.12 16.27 0.00 750.19 0.00 5,000.00 invest
Motilal Oswal Nasdaq Q 50 ETF 75.9192 1.25 37.03 0.00 0.00 45.31 0.47 500.00 invest
Mirae Asset Hang Seng TECH ETF 16.5079 -1.27 26.78 -5.31 0.00 314.65 0.00 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2024 207.54 24.69 -2.89
Equity-Cipla Nov 30, 2024 90.99 10.83 -0.34
Equity-Divi`s Lab. Nov 30, 2024 84.60 10.06 5.67
Equity-Dr Reddy`s Labs Nov 30, 2024 79.14 9.42 -4.87
Equity-Lupin Nov 30, 2024 53.34 6.35 -5.46
Equity-Aurobindo Pharma Nov 30, 2024 38.10 4.53 -8.84
Equity-Torrent Pharma. Nov 30, 2024 33.13 3.94 4.64
Equity-Alkem Lab Nov 30, 2024 31.80 3.78 -1.60
Equity-Zydus Lifesci. Nov 30, 2024 26.07 3.10 -2.73
Equity-Mankind Pharma Nov 30, 2024 26.08 3.10 -3.18

latest news

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 13 December 2024 as the record date ...

Dec 11, 2024 09:26

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 14 November 2024 as the record date ...

Nov 12, 2024 09:59

Nippon India Mutual Fund announces change in Exit Load Structure

Nippon India Mutual Fund has announced change in exit load structure under ...

Oct 14, 2024 14:01

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 15 October 2024 as the record date f...

Oct 11, 2024 09:48

Nippon India Mutual Fund announces merger of Nippon India ETF Nifty CPSE Bond Plus SDL Sep 2024 50:50 merger into Nippon India Nifty AAA CPSE Bond Plu

Nippon India Mutual Fund has approved the merger of Nippon India ETF Nifty ...

Sep 16, 2024 11:10

Groww Mutual Fund announces change in Exit Load Structure

Groww Mutual Fund has announced change in exit load structure under followi...

Sep 14, 2024 12:47

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Nifty Pharma ETF
Contact Persone : Himanshu Mange
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com